Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis III
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
T. Petrenko, P. Filimonov, V. Krasnov (Novosibirsk, Russian Federation). Morphological evidence of anti-inflammatory effect of interferon-α at pulmonary TB patients. Eur Respir J 2008; 32: Suppl. 52, 2489

Member's Comments

No comment yet.

Related content which might interest you: Evolution of systemic response in patients with pulmonary sarcoidosis of different course of the disease during anti-inflammatory treatment Source: Annual Congress 2009 - Sarcoidosis in review Year: 2009 Side effects of antituberculosis drugs in treatment of patients with newly detected pulmonary tuberculosis Source: Eur Respir J 2007; 30: Suppl. 51, 197s Year: 2007 The effect of anti-inflammatory treatment to the pleural thickening in tuberculosis pleuresy Source: Eur Respir J 2004; 24: Suppl. 48, 722s Year: 2004 Real-world antifibrotic treatment persistence and clinical outcomes for patients with idiopathic pulmonary fibrosis Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021 Survival and course of lung function in the presence or absence of antifibrotic treatment in patients with idiopathic pulmonary fibrosis: long-term results of the INSIGHTS-IPF registry Source: Eur Respir J, 56 (2) 1902279; 10.1183/13993003.02279-2019 Year: 2020 Survival on antifibrotic therapy in IPF – the impact of pleural plaques, concomitant emphysema and definite vs possible UIP Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia Year: 2019 The effect of pulmonary rehabilitation programme in patients with pulmonary sarcoidosis Source: Annual Congress 2011 - Rehabilitation, outcome measures and effects Year: 2011 The efficacy of treatment with surfactant-BL (S-BL) in patients with destructive pulmonary tuberculosis Source: Annual Congress 2007 - Research perspectives: diagnosis and treatment of tuberculosis Year: 2007 Late Breaking Abstract - The outcome of COVID-19 in interstitial lung disease patients treated with anti-inflammatory drugs and antiviral drugs Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases Year: 2021 Antituberculous activity of fiurenizid in vitro and in patients with destructive pulmonary tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 724s Year: 2004 Comparative analysis of the efficacy of glucocorticosteroids and antimetabolite drugs in treatment of patients with pulmonary sarcoidosis Source: International Congress 2019 – Granulomatous disorders: pathogenesis, epidemiology and clinical issues Year: 2019 Potential synergism of drugs with anti-viral and pulmonary oedema clearance activity may be advantageous for influenza patients Source: Annual Congress 2011 - Insight into mechanisms of respiratory infections Year: 2011 The efficacy of anti-fibrotic agents for acute exacerbation of idiopathic pulmonary fibrosis Source: International Congress 2017 – Idiopathic pulmonary fibrosis: from the bench to the bedside Year: 2017 Effect of drugs with pleiotropic properties on tone of pulmonary arteries and bronchi in obstructive lung pathology model Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease Year: 2015 Effectiveness of treatment and correction of side effects in pulmonary MDR/XDR TB patients with concomitant liver injury Source: International Congress 2017 – Paediatric TB: MDRTB (II) Year: 2017 Effects of pulmonary rehabilitation on systemic and pulmonary inflammation in COPD patients Source: Annual Congress 2010 - Exercise in COPD Year: 2010 The pulmonary microbiome and immunological activity in IPF patients. Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis Year: 2020 The effect of augmentation therapy on systemic and pulmonary inflammation markers in α1-antitrypsin deficiency patients Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases Year: 2010 The effect of smoking on successfully treated pulmonary tuberculosis patients Source: Eur Respir J 2007; 30: Suppl. 51, 420s Year: 2007 Clinical effectiveness of steroid treatment on lung function and immunologic markers in pulmonary sarcoidosis Source: Eur Respir J 2007; 30: Suppl. 51, 86s Year: 2007